Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRophylaxis Against Early VENTilator-associated Infections to Reduce Mortality in Mechanically Ventilated Intensive Care Unit (ICU) Patients With Acute Brain Injuries: a Phase 3 Randomised, Double Blind, Parallel Group, Placebo-controlled Two-side Superiority Trial

NCT06819592 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT06819592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06819592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRophylaxis Against Early VENTilator-associated Infections to Reduce Mortality in Mechanically Ventilated Intensive Care Unit (ICU) Patients With Acute Brain Injuries: a Phase 3 Randomised, Double Blind, Parallel Group, Placebo-controlled Two-side Superiority Trial
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Recruiting
Start date
October 30, 2025
Completion date
December 31, 2029
Enrollment
3,300 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

acute brain injury, all-cause mortality, disability, intellectual, intensive care medicine, neurological disorder, quality of life, ventilation, mechanical